Marissa Termini
Adult Health · Bay Shore, NYNPI 1154932895
Payments from drug & device makers
Across 160 payments — averaging $40.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$1K
- Johnson & Johnson$765
- Medtronic$480
- E.r. Squibb & Sons, L.L.C.$458
- Boehringer Ingelheim$448
- AstraZeneca$436
- plus $3K from 18 others
What the payments were for
- Travel & lodging$2404%
- Food & beverage$6,15894%
- Education$1282%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 21 | $1,237 |
| Johnson & Johnson | 15 | $765 |
| Medtronic | 14 | $480 |
| E.r. Squibb & Sons, L.L.C. | 8 | $458 |
| Boehringer Ingelheim | 9 | $448 |
| AstraZeneca | 7 | $436 |
| Sanofi-aventis U.S. LLC | 9 | $409 |
| Novartis | 16 | $316 |
| Merck | 16 | $298 |
| Inspire Medical Systems, Inc. | 1 | $290 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 10 | $273 |
| Boston Scientific | 5 | $177 |
| Regeneron Healthcare Solutions, Inc. | 3 | $155 |
| Philips North America LLC | 2 | $137 |
| Bardy Diagnostics, Inc. | 1 | $128 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $125 |
| Amgen | 6 | $101 |
| Pfizer | 4 | $74 |
| Esperion Therapeutics, Inc. | 4 | $65 |
| Tactile Systems Technology Inc | 2 | $43 |
| Novo Nordisk | 2 | $39 |
| Kowa Pharmaceuticals America, Inc. | 2 | $29 |
| Bayer | 1 | $23 |
| Scpharmaceuticals Inc. | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- XARELTO$469
- CARDIOMEMS$406
- FARXIGA$377
- JARDIANCE$354
- Inspire Upper Airway Stimulation System$290
- CAMZYOS$252
- Micra$240
- JOT DX$167
- CardioMEMS HF System$158
- Carnation Ambulatory Monitor$128
- MULTAQ$125
- NURTEC ODT$125
- Accessories$121
- ELIQUIS$118
- EVKEEZA$112
- AMPLATZER TALISMAN$107
- RESONATE EL ICD VR$107
- LifeVest$104
How this compares
$6,526 in reported general payments places this provider in the 90th percentile of 3,828 adult health providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 83 | $104,227 |
| XareltoRivaroxaban | 30 | $41,754 |
| EntrestoSacubitril/Valsartan | 23 | $28,789 |
| MultaqDronedarone Hcl | 15 | $19,336 |
| JardianceEmpagliflozin | 11 | $7,619 |
| Metoprolol Succinate | 99 | $2,109 |
| Rosuvastatin Calcium | 67 | $943 |
| Atorvastatin Calcium | 76 | $849 |
| Ezetimibe | 15 | $635 |
| Bumetanide | 13 | $519 |
| Losartan Potassium | 40 | $482 |
| Amlodipine Besylate | 83 | $404 |
| ClopidogrelClopidogrel Bisulfate | 31 | $351 |
| Lisinopril | 33 | $300 |
| Spironolactone | 20 | $262 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $74 | $104,22783 claims |
| Johnson & JohnsonXarelto | $765 | $41,75430 claims |
| NovartisEntresto | $316 | $28,78923 claims |
| Sanofi-aventis U.S. LLCMultaq | $409 | $19,33615 claims |
| Boehringer IngelheimJardiance | $448 | $7,61911 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,828 adult health providers in New York.
Other adult health in Bay Shore
- Barbara BumsteadBay Shore$52K
- Marguerite CallahanNew York$1.4M
- Donna CatameroNew York$279K
- Kristen DurkinPort Jefferson Station$255K
- Katelyn McCormackAmherst$201K
- Mary CiechoskiBuffalo$200K
- Patricia LorussoLancaster$161K
- Jennifer FioriniGlens Falls$151K
- Tia AlbroRochester$142K
- Maria Gigante-BaggettEast Syracuse$92K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.